These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 10364294)

  • 1. Use of major histocompatibility complex class I/peptide/beta2M tetramers to quantitate CD8(+) cytotoxic T lymphocytes specific for dominant and nondominant viral epitopes in simian-human immunodeficiency virus-infected rhesus monkeys.
    Egan MA; Kuroda MJ; Voss G; Schmitz JE; Charini WA; Lord CI; Forman MA; Letvin NL
    J Virol; 1999 Jul; 73(7):5466-72. PubMed ID: 10364294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex.
    Kuroda MJ; Schmitz JE; Barouch DH; Craiu A; Allen TM; Sette A; Watkins DI; Forman MA; Letvin NL
    J Exp Med; 1998 May; 187(9):1373-81. PubMed ID: 9565630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definition of human immunodeficiency virus type 1 gp120 and gp41 cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I alleles in simian-human immunodeficiency virus-infected rhesus monkeys.
    Voss G; Letvin NL
    J Virol; 1996 Oct; 70(10):7335-40. PubMed ID: 8794394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simian immunodeficiency virus nef peptide is a dominant cytotoxic T lymphocyte epitope in Indian-origin rhesus monkeys expressing the common MHC class I allele mamu-A*02.
    Newberg MH; Kuroda MJ; Charini WA; Miura A; Lord CI; Schmitz JE; Gorgone DA; Lifton MA; Kuus-Reichel K; Letvin NL
    Virology; 2002 Sep; 301(2):365-73. PubMed ID: 12359438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys.
    Barouch DH; Craiu A; Santra S; Egan MA; Schmitz JE; Kuroda MJ; Fu TM; Nam JH; Wyatt LS; Lifton MA; Krivulka GR; Nickerson CE; Lord CI; Moss B; Lewis MG; Hirsch VM; Shiver JW; Letvin NL
    J Virol; 2001 Mar; 75(5):2462-7. PubMed ID: 11160750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel simian immunodeficiency virus CTL epitopes restricted by MHC class I molecule Mamu-B*01 are highly conserved for long term in DNA/MVA-vaccinated, SHIV-challenged rhesus macaques.
    Su J; Luscher MA; Xiong Y; Rustam T; Amara RR; Rakasz E; Robinson HL; MacDonald KS
    Int Immunol; 2005 May; 17(5):637-48. PubMed ID: 15824066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of cytotoxic T lymphocytes in lymph nodes and peripheral blood of simian immunodeficiency virus-infected rhesus monkeys.
    Kuroda MJ; Schmitz JE; Charini WA; Nickerson CE; Lord CI; Forman MA; Letvin NL
    J Virol; 1999 Feb; 73(2):1573-9. PubMed ID: 9882363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques.
    Malkevitch N; Patterson LJ; Aldrich K; Richardson E; Alvord WG; Robert-Guroff M
    J Immunol; 2003 Apr; 170(8):4281-9. PubMed ID: 12682263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunodomination in the evolution of dominant epitope-specific CD8+ T lymphocyte responses in simian immunodeficiency virus-infected rhesus monkeys.
    Newberg MH; McEvers KJ; Gorgone DA; Lifton MA; Baumeister SH; Veazey RS; Schmitz JE; Letvin NL
    J Immunol; 2006 Jan; 176(1):319-28. PubMed ID: 16365424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence?
    Vogel TU; Friedrich TC; O'Connor DH; Rehrauer W; Dodds EJ; Hickman H; Hildebrand W; Sidney J; Sette A; Hughes A; Horton H; Vielhuber K; Rudersdorf R; De Souza IP; Reynolds MR; Allen TM; Wilson N; Watkins DI
    J Virol; 2002 Nov; 76(22):11623-36. PubMed ID: 12388723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus type 1 envelope epitope-specific CD4(+) T lymphocytes in simian/human immunodeficiency virus-infected and vaccinated rhesus monkeys detected using a peptide-major histocompatibility complex class II tetramer.
    Kuroda MJ; Schmitz JE; Lekutis C; Nickerson CE; Lifton MA; Franchini G; Harouse JM; Cheng-Mayer C; Letvin NL
    J Virol; 2000 Sep; 74(18):8751-6. PubMed ID: 10954578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of TCRalphabeta combinations used by simian immunodeficiency virus-specific CD8+ T cells in rhesus monkeys: implications for CTL immunodominance.
    Hasegawa A; Moriya C; Liu H; Charini WA; Vinet HC; Subbramanian RA; Sen P; Letvin NL; Kuroda MJ
    J Immunol; 2007 Mar; 178(6):3409-17. PubMed ID: 17339435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection.
    Mothé BR; Horton H; Carter DK; Allen TM; Liebl ME; Skinner P; Vogel TU; Fuenger S; Vielhuber K; Rehrauer W; Wilson N; Franchini G; Altman JD; Haase A; Picker LJ; Allison DB; Watkins DI
    J Virol; 2002 Jan; 76(2):875-84. PubMed ID: 11752176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testing.
    Allen TM; Mothé BR; Sidney J; Jing P; Dzuris JL; Liebl ME; Vogel TU; O'Connor DH; Wang X; Wussow MC; Thomson JA; Altman JD; Watkins DI; Sette A
    J Virol; 2001 Jan; 75(2):738-49. PubMed ID: 11134287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition.
    Loffredo JT; Sidney J; Wojewoda C; Dodds E; Reynolds MR; Napoé G; Mothé BR; O'Connor DH; Wilson NA; Watkins DI; Sette A
    J Immunol; 2004 Oct; 173(8):5064-76. PubMed ID: 15470050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus.
    Allen TM; Sidney J; del Guercio MF; Glickman RL; Lensmeyer GL; Wiebe DA; DeMars R; Pauza CD; Johnson RP; Sette A; Watkins DI
    J Immunol; 1998 Jun; 160(12):6062-71. PubMed ID: 9637523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dominant CD8+ T-lymphocyte responses suppress expansion of vaccine-elicited subdominant T lymphocytes in rhesus monkeys challenged with pathogenic simian-human immunodeficiency virus.
    Manuel ER; Yeh WW; Seaman MS; Furr K; Lifton MA; Hulot SL; Autissier P; Letvin NL
    J Virol; 2009 Oct; 83(19):10028-35. PubMed ID: 19641002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus gag.
    Chen ZW; Shen L; Miller MD; Ghim SH; Hughes AL; Letvin NL
    J Immunol; 1992 Dec; 149(12):4060-6. PubMed ID: 1460291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simian immunodeficiency virus envelope V3 cytotoxic T-lymphocyte epitope in rhesus monkeys and its restricting major histocompatibility complex class I molecule Mamu-A*02.
    Watanabe N; McAdam SN; Boyson JE; Piekarczyk MS; Yasutomi Y; Watkins DI; Letvin NL
    J Virol; 1994 Oct; 68(10):6690-6. PubMed ID: 7521921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simian immunodeficiency virus evades a dominant epitope-specific cytotoxic T lymphocyte response through a mutation resulting in the accelerated dissociation of viral peptide and MHC class I.
    Chen ZW; Craiu A; Shen L; Kuroda MJ; Iroku UC; Watkins DI; Voss G; Letvin NL
    J Immunol; 2000 Jun; 164(12):6474-9. PubMed ID: 10843704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.